Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Khemka, Vineet Kumara | Bagchi, Debajita | Bandyopadhyay, Kausika | Bir, Aritria | Chattopadhyay, Mrittikaa | Biswas, Atanub | Basu, Debasisa | Chakrabarti, Sasankaa; *
Affiliations: [a] Department of Biochemistry, Institute of Post Graduate Medical Education and Research, Kolkata, India | [b] Department of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, India
Correspondence: [*] Correspondence to: Sasanka Chakrabarti, Head, Department of Biochemistry, Institute of Post Graduate Medical Education and Research, 244 A J C Bose Road, Kolkata-700020, India. Tel.: +913364526168; Fax: +913322234413; E-mail: profschakrabarti95@gmail.com.
Abstract: Cerebral hypometabolism of glucose, weight loss, and decreased food intake are characteristic features of sporadic Alzheimer's disease (AD). A systematic study on the serum levels of adipokines and insulin, the major hormones regulating energy metabolism, food intake, and body weight, in sporadic AD is necessary. The present study compares the serum levels of leptin, adiponectin, and insulin, measured by commercially available immuno-assay kits, between controls and sporadic AD subjects. The results show a conspicuous decrease in the level of leptin, a dramatic rise in the level of adiponectin, and also a statistically significant increase in insulin level, in the blood of AD subjects, with respect to controls. The changes in the serum levels of adiponectin and insulin in AD are positively correlated with the severity of dementia. Likewise, the serum level of leptin in AD subjects is negatively correlated with the degree of dementia. The changes in the levels of adipokines and insulin have implications in the amyloid pathology, neurodegeneration, and hypometabolism of glucose existing in the AD brain.
Keywords: Adiponectin, Alzheimer's disease, amyloid-β, insulin, leptin
DOI: 10.3233/JAD-140006
Journal: Journal of Alzheimer's Disease, vol. 41, no. 2, pp. 525-533, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl